Samsung Epis Launches China R&D Center, Secures Hub for ADC New Drug Development
First Global R&D Initiative Since Transition to Bio Investment Holding Company
Samsung Epis Holdings, the bio investment holding company of Samsung, has officially launched its research and development (R&D) hub in China, aiming to strengthen its capabilities in new drug development.
Paik Kyung-ah, President of Samsung Epis Holdings (6th from the left), and key guests are attending the opening ceremony of the China R&D center and taking a commemorative photo. Samsung Epis Holdings
View original imageSamsung Epis Holdings announced on July 1 that it held the opening ceremony for 'Samsung Bioepis (China) Co., Ltd.' on June 30 in Changping District, Beijing, China, and has begun full-scale R&D activities.
The China R&D center is Samsung Epis Holdings' first overseas research and development hub, established to secure next-generation bio technology platforms such as antibody-drug conjugates (ADCs) and to enhance its capabilities in new drug development. The company plans to utilize local research infrastructure and the bio ecosystem to expand the discovery of innovative drug candidates.
Changping District in Beijing, where the center is located, is home to the Zhongguancun Life Science Park, an advanced bio technology industrial complex. The area is considered advantageous for securing outstanding research talent and infrastructure, as it is adjacent to major research institutions such as Peking University and Tsinghua University.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Kim Kyung-Ah, President of Samsung Epis Holdings, said, "With the opening of the China R&D Center, we have taken the first step towards establishing a global R&D network. We will continue to expand our new business by closely collaborating with the Chinese bio ecosystem to discover innovative drug candidates."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.